Web9 jan. 2024 · Royalty Pharma to acquire an interest in SPINRAZA ® and pelacarsen royalties -- Ionis retains majority of royalties and all milestones from Novartis for pelacarsen; Royalty Pharma to pay Ionis $500 million upfront and up to $625 million in milestones ; Agreement enables Ionis to achieve commercial readiness for multiple late-stage … WebIonis Pharmaceuticals University of California, Berkeley Websites About Dr. Ecker’s career accomplishments include co-founding three companies. He was trained as a biochemist with an...
Royalty Pharma and Ionis Enter Into Royalty Agreement for Up to …
WebIonis Pharmaceuticals, Inc. beschäftigt sich mit der Entdeckung und Entwicklung von Ribonukleinsäure (RNA)-gezielten Therapeutika. Das Unternehmen konzentriert sich in erster Linie auf die Bereiche Herz-Kreislauf und Neurologie. WebWho is Ionis Pharmaceuticals Headquarters 2855 Gazelle Ct, Carlsbad, California, 92010, United States Phone Number (760) 931-9200 Website www.ionispharma.com Revenue $587.4M Stock Symbol IONS Industry Pharmaceuticals Healthcare Ionis Pharmaceuticals's Social Media Is this data correct? View contact profiles from Ionis … marble diagram
Investor FAQ Ionis Pharmaceuticals, Inc.
Web7 apr. 2024 · Ionis Pharmaceuticals announced this morning that it is pivoting from its original drug candidate for prion disease, ION716, to a new drug candidate. Ionis reaffirmed its commitment to developing a drug for prion disease, and stated a current goal of launching human trials in late 2024. Web10 apr. 2024 · Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. About the company Rewards Trading at 83.7% below our estimate of its fair value Revenue is forecast to grow 17.52% per year Risk Analysis Currently unprofitable and not forecast to become profitable over the next 3 years Web9 dec. 2024 · 2024 Investor Day. December 9, 2024. Nasdaq: IONS. 2024 INVESTOR DAY. Participating in Today's Presentation. There will be one Q&A session at the end of today's program. Submit questions in the "Ask a Question" field and click send. A replay will be available on the Investors page of the Ionis website later today. marble diagram generator